LAB MEMBERS
啐啄同時
Embedded Files
Current Members
Current Members
Sung Kyung Choi, PhD
Sung Kyung Choi, PhD
Postdoc: 2025.09 ~
Postdoc: 2020.03 ~ 2025.08 Konkuk University School of Medicine
MS-PhD: 2014.09 ~ 2020.02 Konkuk University School of Medicine
Research Keywords
- Chromatin remodeler, SWI/SNF complex, HELLS, Mitochondria dynamics, Histone modificationResearch Focus
- Nuclear–mitochondrial communication
- Mitochondrial dynamics & metabolic signaling in cancerSelected Publications
- HELLS controls mitochondrial dynamics and genome stability in liver cancer by collusion with MIEF1. Cell Death Dis. 2025 Apr 2;16(1):239
- αKG-induced oxidative stress and mTOR inhibition as a therapeutic strategy for liver cancer. Medical Oncology. 2025 Mar 13;42(4):105
Yena Cho, MS-PhD candidate
Yena Cho, MS-PhD candidate
MS-PhD course: 2022.03 ~
Research Associate: 2020.01 ~ 2022.02
PRMT regulation of cellular homeostasis:
- Mitochondrial dynamics and energy homeostasis
- Cell cycle & mitosis
- Microtubule dynamicsSelected Publications:
- Multifaceted roles of CARM1 beyond histone arginine methylation. Exp Mol Med. 2025
- ROS-mediated cytoplasmic localization of CARM1 induces mitochondrial fission through DRP1 methylation. Redox Biol. 2024, 73:103212
- CARM1 regulates tubulin autoregulation through PI3KC2α R175 methylation. Cell Commun Signal. 2025, 23:120
Yena's publication List
Yena's publication List
Multilayered Regulation of Cytoskeletal Protein Abundance: Autoregulatory Mechanisms of Actin and Tubulin
Y Cho, YK Kim*
Experimental & Molecular Medicine, 2025 (accepted) [12.9, 4.2%]Context-specific applications of CARM1 inhibitors: functional profiles of EZM2302 and TP-064
Y Cho, YK Kim*
Molecular Medicine, 2025; 31(1), 322 [6.4, 15.0%] [PDF]
Y Cho, YK Kim*
Experimental & Molecular Medicine, 2025; 57, 2251-2263 [12.9, 4.2%] [PDF]🗞️ SM NEWS, BRIC,교수신문
Reversible arginine methylation of PI3KC2α controls mitotic spindle dynamics
Y Cho, JW Hwang, MT Bedford, DH Na, DG Song, SN Kim, YK Kim*
Cell Communication and Signaling, 2025; 23(1), 409 [8.9, 15.2%] [PDF]CARM1 S217 phosphorylation by CDK1 in late G2 phase facilitates mitotic entry
Y Cho, DG Song, SN Kim, YK Kim*
Cell Death & Disease, 2025; 16 (1), 202 [8.1, 15.9%] [PDF]CARM1 regulates tubulin autoregulation through PI3KC2α R175 methylation
Y Cho, JW Hwang, MT Bedford, DG Song, SN Kim, YK Kim*
Cell Communication and Signaling, 2025; 23 (1), 120 [8.2, 15.4%] [PDF]CARM1 phosphorylation at S595 by p38γ MAPK drives ROS-mediated cellular senescence
Y Cho, YK Kim*
Redox Biology, 2024; 76, 103344 [10.7, 5.3%] 🗞️SM NEWS, BRIC, 한겨레, 대학신문, 약사공론ROS-mediated cytoplasmic localization of CARM1 induces mitochondrial fission through DRP1 methylation
Y Cho, YK Kim*
Redox Biology, 2024; 73, 103212 [10.7, 5.3%] 🗞️SM NEWS, BRIC, 대학신문, 데일리팜SPC-180002, a SIRT1/3 dual inhibitor, impairs mitochondrial function and redox homeostasis and represents an antitumor activity
Y Cho, JW Hwang, NJ Park, J Moon, KH Ali, YH Seo, IS Kim*, SN Kim*, YK Kim*
Free Radical Biology and Medicine, 2023; 208, 73-87 [7.4, 11.0%] 🗞️숙약뉴스PRMT7 inhibitor SGC8158 enhances doxorubicin-induced DNA damage and its cytotoxicity
A Jeong, Y Cho, M Cho, GU Bae, DG Song, SN Kim*, YK Kim*
International Journal of Molecular Sciences, 2022; 23 (20), 12323 [5.6, 20.9%]A novel synthetic microtubule inhibitor exerts antiproliferative effects in multidrug resistant cancer cells and cancer stem cells
M Park, JW Hwang, Y Cho, S Kim, SH Han, J Yu, S Ha, WY Kim, SN Kim, IS Kim*, YK Kim*
Scientific Reports, 2021; 11 (1), 10822 [4.997, 19.3%]Protein arginine methyltransferases: promising targets for cancer therapy
JW Hwang, Y Cho, GU Bae, SN Kim, YK Kim*
Experimental & Molecular Medicine, 2021; 53 (5), 788-808 [8.718, 5.4%] 🗞️BRICCancer stem cells as a potential target to overcome multidrug resistance
Y Cho, YK Kim*
Frontiers in Oncology, 2020; 10, 764 [4.848, 33.1%]
Yena's Fellowships and Awards
Yena's Fellowships and Awards
Grants and Fellowships:
Sep. 2024 – Aug. 2026 The PhD Candidate Fellowship (박사과정생연구장려금, RS-2024-00412728), from National Research Foundation (NRF)
Awards:
2025.11 The Next-Generation Pharmacologist Award (차세대 약리학자상) from the Korean Society of Pharmacology (KSP)
2025.10 The Outstanding Young Researcher Award (미래약학우수논문상) from the Pharmaceutical Society of Korea (PSK)
2025.09 Moon Sook Saebyul Award (문숙 새별여성과학자상) from Women’s Bioscience Forum (WBF)
2023.10 The Outstanding Poster Presentation Award from the 2023 Fall International Convention of the Pharmaceutical Society of Korea (PSK)
2023.04 The Outstanding Poster Presentation Award from the 2023 Spring International Convention of the Pharmaceutical Society of Korea (PSK)
Seo Hui Park, MS candidate
Seo Hui Park, MS candidate
MS course: 2025.03 ~
PRMT regulation of cellular homeostasis: PRMT inhibitors
Research Projects:
- Functional divergence of PRMT5 inhibitors and their therapeutic applicationsAwards:
- 2025.10 The Oral Presentation Award from the 2025 Fall International Convention of the Pharmaceutical Society of Korea (PSK)🗞️ SM NEWS
Yeon Gyeong Woo, MS candidate
Yeon Gyeong Woo, MS candidate
Intern: 2025.01 ~ 08
MS course: 2025.09 ~
PRMT regulation of cellular homeostasis:
- Energy homeostasis
- AutophagyResearch:
- CARM1 story
Yoonae Jeong, undergraduate
Yoonae Jeong, undergraduate
Intern: 2024.03 ~
A novel strategy for treating intractable diseases
- RIOK1 inhibitors
- Drug repositioningExperimental Languages:
- Cell culture, MTT assay, Western blot, RT-qPCR etc
Do-yeon Park, research intern
Do-yeon Park, research intern
Intern: 2025.08 ~
A novel strategy for treating intractable diseases
- RIOK1 inhibitors
- Drug repositioningExperimental Languages:
- Cell culture, MTT assay, Western blot, RT-qPCR etc
Alumni - graduate
Alumni - graduate
Ahyeon Jeong, MS
Ahyeon Jeong, MS
MS 2021.03 ~ 2023.02
Current Position: Arum Therapeutics (2023.07 ~)
Dissertation: PRMT7 inhibitor SGC8158 enhances doxorubicin-induced DNA damage and its cytotoxicity.
Research: PRMT7 & DNA damage response
Publication: IJMS
Jee Won Hwang, PhD
Jee Won Hwang, PhD
PhD 2012.03 ~ 2017.08
Research Professor: 2017.09 ~ 2021.08
Current Position: PostDoc. MD Anderson Cancer Center (Dr. Santos Lab, 2021.08 ~)
Dissertation: Regulation of PRMT5 activity by tyrosine phosphorylation: Its involvement of DNA repair process
Research: regulation of genomic instability and cellular homeostasis by PRMTs
Publications: Nat Commun, Commun Biol etc
Mina Park, MS
Mina Park, MS
MS 2017.09 ~ 2020.02
Research Associate: 2020.03 ~ 2020.08
Current Position: PhD course, Graduate school, Hanyang University Molecular Life Science
Dissertation: Anti-proliferative effect of the substituted chromone on multidrug resistant cancer cells
Research: novel strategies to overcome MDR cancer: 5-(N-methylmaleimid-3-yl)-chromone
Publication: Sci Rep
Nayeon Myung, MS
Nayeon Myung, MS
MS 2015.03 ~ 2017.02
Research Associate: 2017.03 ~ 2017.08
Current Position: SK Bioscience -> Handok
Dissertation: Regulation of cell cycle progression and cell growth by CARM1
Research: regulation mechanisms of PRMTs: their implication in genomic instability and cellular homeostasis
Publication: Nat Commun, Commun Biol
Yun-Sung Soh, MS
Yun-Sung Soh, MS
MS 2013.03 ~ 2015.02
Current Position: SAMSUNG Bioepis
Dissertation: Negative regulation of PPARγ transcriptional activity by protein arginine methyltransferase 6
Research: regulation mechanisms of PRMTs: their implication in cellular homeostasis
Publication: Int J Mol Med
Hyeonjeong Seol, MS
Hyeonjeong Seol, MS
MS 2012.03 ~ 2014.02
Current Position: Community Pharmacy, Seoul
Dissertation: Expression of PRMT5 on the response to hypoxia
Research: regulation mechanisms of PRMTs: their implication in cellular homeostasis
Kyoung-Youn Han, Post Doc
Kyoung-Youn Han, Post Doc
2011.10 ~ 2014.08
Current Position:
Research: regulation mechanisms of PRMTs: their implication in cellular homeostasis
Publication: Mol Med Rep
So Hee Kim, research associate
So Hee Kim, research associate
2012.03 ~ 2013.02
Current Position:
Research: regulation mechanisms of PRMTs: their implication in cellular homeostasis
Alumni - undergraduate
Alumni - undergraduate
Na Yeon Kim, research intern
Na Yeon Kim, research intern
Intern: 2025.01 ~ 2025.04
A novel strategy for treating intractable diseases
- Drug repositioningExperimental Languages:
- Cell culture, MTT assay, Western blot, RT-qPCR etc
Sunwoo Hyeon, MS course
Sunwoo Hyeon, MS course
MS course: 2024.02 ~ 06, leave of absence
from Inje University
Experimental Language:
- Cell culture, MTT assay, Western blot, RT-qPCR etc
Jeong Yeon Yang, undergraduate
Jeong Yeon Yang, undergraduate
Intern: 2023.08 ~ 2024.02
from Division of Biological Sciences, Sookmyung Women's Univ
Experimental Language: Cell culture, MTT assay, Western blot, RT-qPCR etc
A novel strategy for the treatment of incurable disease (RIOK1 inhibitors and H2 blockers)
Yoo Soo Kim, MS course
Yoo Soo Kim, MS course
MS course 2022.03 ~ 06, leave of absence
Internship: 2018.07 ~ 2018.12
Current Position: KOEDC
Biological roles of protein arginine methylation:
- ID and characterization of novel PRMT substrates
SW Kwon, PharmD 22.12~23.05 Internship (22.12.19~23.05.31)
YW Na, PharmD 22.12~23.02 Internship (22.12.19~23.02.24)
SJ Choi, PharmD 22.08~22.10 APPE (22.08.01~22.10.07)
JY Han 22.07~22.08 Internship (from Department of Biology Science, Chosun University)
MK Cho, PharmD 22.01~23.05 Internship (22.01.01~22.2.28, 22.07.01~23.05.31]: DNA damage response and PRMTs
JH Lee 22.01~22.02 Internship (from Department of Integrative Bioscience and Biotechnology, KKU)
HJ Kwon, PharmD 21.07~23.03 Internship, Research Associate, APPE (22.12.26~23.03.03): Regulation of Autophagy by PRMTs
YH Kim, PharmD 21.07~21.08 Internship (22.01~22.02)
SM Kim, PharmD 21.01~21.02 InternshipㅣHospital Pharmacy, Seoul
SJ Hong, PharmD 21.01~21.02 Internship
Y Hong, PharmD 21.06~21.08 APPEㅣHospital Pharmacy, Seoul
YI Kim, PharmD 20.07~20.12 Internship
Y Cho, PharmD 20.01~22.02 Internship, Research Associate, APPEㅣSMWU graduate school (22.03~)
SY Jang, PharmD 19.01~19.06 InternshipㅣSNU graduate school (MS, 21.03~23.02)ㅣWhan In Pharm Co.,Ltd.
HK Seon, PharmD 18.01~18.02 InternshipㅣHospital Pharmacy, Seoul
YS Kim, PharmD 18.07~18.12 InternshipㅣHospital Pharmacy, SeoulㅣSMWU graduate school (22.03~05)
SK Lee, PharmD 17.07~17.08 InternshipㅣHospital Pharmacy, Seoul
TK Lee, PharmD 17.07~17.08 InternshipㅣHospital Pharmacy, Seoul
YJ Seon, PharmD 13.07~13.08 Internship
YY Jin, PharmD 12.07~12.08 Internship
JY Lee, PharmD 12.07~13.02 InternshipㅣSKKU graduate school (MS, 15.03~17.02)
SJ Kim, PharmD 12.01~13.02 InternshipㅣCRO company, UKㅣUCL graduate school, UK
Page updated
Google Sites
Report abuse